sub:assertion {
  d:DB00592 v:identifier "DB00592" ;
    v:namespace "drugbank" ;
    v:uri "http://bio2rdf.org/drugbank:DB00592" ;
    v:x-identifiers.org <http://identifiers.org/drugbank/DB00592> ;
    dv:drugbank-id "APRD00225" , "DB00592" ;
    dv:x-ahfs <http://bio2rdf.org/ahfs:08:08.00> ;
    dv:x-atc <http://bio2rdf.org/atc:P02CB01> ;
    dv:x-cas <http://bio2rdf.org/cas:110-85-0> ;
    dv:x-chebi <http://bio2rdf.org/chebi:28568> ;
    dv:x-chemspider <http://bio2rdf.org/chemspider:13835459> ;
    dv:x-dpd <http://bio2rdf.org/dpd:97128> ;
    dv:x-kegg <http://bio2rdf.org/kegg:C07973> , <http://bio2rdf.org/kegg:D00807> ;
    dv:x-pdb <http://bio2rdf.org/pdb:169> ;
    dv:x-pharmgkb <http://bio2rdf.org/pharmgkb:PA450977> ;
    dv:x-pubchemcompound <http://bio2rdf.org/pubchem.compound:4837> ;
    dv:x-pubchemsubstance <http://bio2rdf.org/pubchem.substance:46507642> ;
    dv:x-wikipedia <http://bio2rdf.org/wikipedia:Piperazine> ;
    dct:description """Piperazine is an organic compound that consists of a six-membered ring containing two opposing nitrogen atoms. Piperazine exists as small alkaline deliquescent crystals with a saline taste.

Piperazine was introduced to medicine as a solvent for uric acid. When taken into the body the drug is partly oxidized and partly eliminated unchanged. Outside the body, piperazine has a remarkable power to dissolve uric acid and producing a soluble urate, but in clinical experience it has not proved equally successful.

Piperazine was first introduced as an anthelmintic in 1953. A large number of piperazine compounds have anthelmintic action. Their mode of action is generally by paralysing parasites, which allows the host body to easily remove or expel the invading organism."""@en ;
    dct:identifier "drugbank:DB00592" ;
    dct:title "Piperazine"@en ;
    a dv:Drug ;
    rdfs:label "Piperazine [drugbank:DB00592]"@en ;
    rdfs:seeAlso <http://www.drugbank.ca/drugs/DB00592> , <http://www.drugs.com/cons/piperazine.html> .
}